{"nct_id":"NCT01339923","title":"A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years","status":"COMPLETED","status_verified_date":"2016-03","start_date":"2011-04","start_date_type":null,"primary_completion_date":"2014-01","primary_completion_date_type":"ACTUAL","completion_date":"2014-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}